Prediction Case File
YouTubeEvaluation Complete

UnitedHealth stock has so far disappointed investors in 2025, but the market could be surprised at its performance next year.

1 extracted signal · 1 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
26 Sept 2025, 15:45 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for UnitedHealth stock has so far disappointed investors in 2025, but the market could be surprised at its performance next year.
Source overview

AI-generated source summary

The video analyzes UnitedHealth stock (UNH). It uses a fundamental approach, citing the fiscal.ai platform for data, particularly forward price-to-earnings ratio (currently at 21.31). Estimates for the fiscal year 2027 earnings per share is at $20.81. Four scenarios are then analyzed. At its current P/E, the stock can potentially reach 443. 23 as the new P/E could increase up to 23 with the share potentially reaching 478 and a 25 P/E reaching $520 dollars, the baseline being at a $440-480 at the end of next year. A fail bound price is 333 due to some mistakes and underestimating cost for customers, that caused decrease in profitability, what is fixable by the management. As such, estimates point it towards a range between $440 and $480 by the end of the timeframe.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
41.8
Tracked signals
1293
Historical success
25.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail